Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
(NASDAQ: SYRE) Delayed: 90.25 -2.43 (2.62%)
Previous Close $92.68    52 Week High $ 
Open $92.82    52 Week Low $ 
Day High $93.34    P/E N/A 
Day Low $89.85    EPS $ 
Volume 3,357,068